| Comirnaty EU/1/20/1528/001 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/002-003 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/004-005 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/010 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/028-031 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years EU/1/20/1528/034 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/032-033 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/035 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/036 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty JN.1 30 micrograms/dose dispersion for injection EU/1/20/1528/028-29 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY KP.2 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/040-041 |
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY KP.2 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/042 |
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year EU/1/20/1528/037-038 |
COVID-19 mRNA vaccine (nucleoside-modified) |
BioNTech Manufacturing GmbH |
— |
| Comirnaty LP.8.1 10 micrograms/dose dispersion for injection EU/1/20/1528/048-049 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY LP.8.1 30 micrograms/dose dispersion for injection EU/1/20/1528/045-046 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| Comirnaty LP.8.1 30 micrograms/dose dispersion for injection in pre-filled syringe EU/1/20/1528/051 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| Comirnaty LP8.1 30 micrograms/dose dispersion for injection in pre-filled syringe EU/1/20/1528/047 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 mcg injection EU/1/20/1528/024 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years EU/1/20/1528/021 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/022 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/023 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/026 |
Raxtozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years EU/1/20/1528/018 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years EU/1/20/1528/019 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years EU/1/20/1528/020 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |